Advertisement
UK markets closed
  • FTSE 100

    8,141.11
    +62.25 (+0.77%)
     
  • FTSE 250

    19,817.48
    +215.50 (+1.10%)
     
  • AIM

    755.59
    +2.47 (+0.33%)
     
  • GBP/EUR

    1.1663
    +0.0007 (+0.06%)
     
  • GBP/USD

    1.2459
    -0.0052 (-0.42%)
     
  • Bitcoin GBP

    50,913.14
    -185.51 (-0.36%)
     
  • CMC Crypto 200

    1,325.53
    -71.00 (-5.09%)
     
  • S&P 500

    5,097.81
    +49.39 (+0.98%)
     
  • DOW

    38,176.23
    +90.43 (+0.24%)
     
  • CRUDE OIL

    83.82
    +0.25 (+0.30%)
     
  • GOLD FUTURES

    2,343.40
    +0.90 (+0.04%)
     
  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     
  • HANG SENG

    17,651.15
    +366.61 (+2.12%)
     
  • DAX

    18,161.40
    +244.12 (+1.36%)
     
  • CAC 40

    8,091.29
    +74.64 (+0.93%)
     

Up 32% in 2022, Is Eli Lilly Stock Still a Buy?

Up 32% in 2022, Is Eli Lilly Stock Still a Buy?

The consumer price index increased 7.7% year over year in October, a solid signal that the inflation rate is now trending in the right direction. The pharma stock Eli Lilly (NYSE: LLY) is chief among these stocks. Let's take a look under the hood at Eli Lilly's fundamentals and valuation to decide.